Journal News

A look into the rice glycoproteome

Ecem Arpaci
By Ecem Arpaci
June 17, 2025

Proteins undergo posttranslational modifications, such as N-glycosylation, during which a sugar chain is added to the amino acid asparagine at specific sites to form a glycoprotein. N-glycosylation aids cell-to-cell communication as well as pathogen interactions in animals, but scientists know little about this modification in plants.

Oryza sativa in a rice field and surrounding natural scenery in Indonesia.
Syariful Msth via Wikimedia Commons
Oryza sativa in a rice field and surrounding natural scenery in Indonesia.

To address this gap, Cong Lei, Xilong Li and Wenjia Li of Yazhouwan National Laboratory and a research team in China developed a metabolic glycan labeling approach, which they used to map N-glycans in rice. In their Molecular & Cellular Proteomics paper, the authors grew Oryza sativa, or rice, with a nutrient mixture containing N-azidoacetylgalactosamine, or GalNAz, an artificial glycan building block they could track over time. GalNAz has a unique chemical group to which the authors attached an affinity tag using click chemistry. This made it possible to study the glycoproteins with liquid chromatography–tandem mass spectrometry.

The team identified hundreds of rice-specific N-linked glycoproteins involved in essential biological processes such as plant growth, starch metabolism and protein processing. In addition, several identified proteins mapped to the endoplasmic reticulum–associated protein degradation, or ERAD, pathways, which maintain a balance between protein folding and degradation. The authors also found the core proteins of this pathway to be N-glycosylated in two human cell lines, suggesting that its regulation is conserved between species.

As changes in N-glycosylation have been linked to disrupted plant development, it is important to shed light on modified proteins and sites. This workflow can be used on other plants to expand our understanding of plant glycoproteomes for agricultural research and biotechnology.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ecem Arpaci
Ecem Arpaci

Ecem Arpaci is a biochemistry student at Imperial College London and a research intern at Radboud University Medical Center. She is an ASBMB Today volunteer contributor.

Related articles

From the journals: MCP
Vanshika Patel
From the journals: MCP
Farah Aziz Annesha
From the journals: MCP
Courtney Chandler

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.